MCV Changes in Athletes: Understanding Mean Corpuscular Volume Variations in Training and Performance
Table of Contents
Introduction
Mean corpuscular volume represents one of the most fundamental yet frequently misunderstood markers in athletic blood work interpretation. This red blood cell index provides essential insight into erythrocyte size and can reveal critical information about iron status, training adaptation, and performance capacity in competitive athletes. MCV is included in the basic blood count and is calculated automatically, at least in Finnish laboratories, and therefore, simply due to the high volume, I often encounter a high MCV value in my work.
In clinical settings, interpreting MCV changes in athletes requires distinguishing between physiological training adaptations and genuine pathological processes—a challenge complicated by the fact that ‘normal’ reference ranges were established in sedentary populations. Normal reference values are defined so that 95% of the general population falls within the reference values. However, most of this population is sedentary, so normal reference values often do not apply to athletes.
Understanding MCV and Its Clinical Significance
Mean corpuscular volume quantifies the average size of red blood cells, expressed in femtoliters (fL). Standard clinical reference ranges typically span around 80-100 fL in many adult laboratories, though these population-based values may not appropriately reflect athletic physiology[1]. The measurement provides essential diagnostic information when evaluating athletes presenting with fatigue, declining performance, or abnormal complete blood count results.
MCV categorizes anemia into three fundamental classifications: microcytic (MCV <80 fL), normocytic (MCV 80-100 fL), and macrocytic (MCV >100 fL)[1]. Each category suggests distinct underlying mechanisms affecting erythropoiesis. In athletic populations, understanding these patterns requires appreciation for both pathological conditions and sport-specific physiological adaptations.
In my experience, when MCV falls outside the reference range it is often below the reference value. Perhaps the most common cause is iron deficiency, with or without anemia. The most common cause is iron deficiency, with or without anemia. In my opinion, MCV does not need to be measured or monitored separately, but only if something else comes into the clinical question, such as investigating anemia.
Training-Induced Plasma Volume Expansion and Dilutional Effects
Regular physical training induces plasma volume expansion by 10-20%[2]. This adaptive response represents beneficial cardiovascular adjustment rather than pathology. Elite endurance athletes often exhibit substantial plasma volume expansion, with professional cyclists and other endurance specialists showing increases that can approach or exceed 20% in some studies, depending on training status and methodology[3].
Research examining male athletes found plasma volume elevated 37.5% in endurance-trained males compared to controls, while female runners demonstrated 18.1% increases[4]. This dilutional effect produces what clinicians term “pseudoanemia” or “dilutional anemia”—hemoglobin concentration below standard reference ranges despite normal or elevated total hemoglobin mass[2].
Importantly, MCV is often relatively stable during isolated plasma volume expansion, compared with hemoglobin and hematocrit, distinguishing this adaptive response from true pathological conditions affecting red blood cell production. Some of my patients may suspect iron deficiency due to low hemoglobin. Especially athletic female patients are susceptible to iron deficiency, as I explained in my article regarding iron markers. However, when MCV remains within the normal range and iron markers are adequate, the finding is often more consistent with dilutional effects of training rather than true iron deficiency anemia.
Acute Training Effects: MCV Changes in Athletes
Acute exercise produces variable MCV responses depending on exercise protocol and timing of measurement. After half-marathon running, MCV significantly increased immediately post-exercise but returned to baseline within three hours[5]. This temporary elevation reflects acute physiological stress rather than sustained pathological changes.
During incremental exercise testing in highly trained athletes, MCV showed no significant changes throughout progressive exertion, recovery, or between different sport specializations[6]. These findings suggest that MCV remains relatively stable during short-term acute physical stress when exercise is performed under controlled laboratory conditions.
However, different patterns may emerge during prolonged competition. Professional cyclists completing a 10-day stage race demonstrated gradual increases in MCV throughout the event, likely reflecting cumulative physiological stress and shifts in erythrocyte populations[7].
As I mentioned earlier, MCV is part of a basic blood count, so an abnormal MCV is often detected as an incidental finding. If an athlete has an abnormal MCV and the patient has recently exercised, it is worth controlling the value again before drawing conclusions.
Chronic Training Adaptations: MCV Changes in Athletes
Chronic endurance training produces distinct MCV patterns depending on training volume, intensity, and athlete status. Amateur cyclists displayed higher MCV values than both sedentary subjects and professional cyclists, whilst professional athletes demonstrated values similar to sedentary controls[3]. This U-shaped relationship suggests complex interactions between training status, plasma volume expansion, and erythropoietic adaptation.
In a comprehensive study of 142 elite athletes across multiple sports, MCV demonstrated stability within normal clinical ranges despite substantial variations in hemoglobin, hematocrit, and iron markers[8]. This stability reinforces MCV utility as a discriminating marker—significant deviations warrant investigation rather than dismissal as training adaptation.
Some evidence suggests endurance training may decrease MCV while high-intensity training increases it, though results remain inconsistent across studies[9]. A 16-week strength exercise program produced significant MCV decreases in previously sedentary women, suggesting training modality influences erythrocyte morphology[10].
So as we can see from above, the research findings are mainly heterogeneous. Although MCV may vary in the short term, in the long term there is no clear consensus that MCV differs significantly in athletes. For this reason, persistent deviations in MCV should not be automatically attributed to training alone. Therefore, I interpret changes in MCV in athletes in the same way as in the general population.
MCV Changes in Athletes: Microcytic and Macrocytic Anemia
Iron deficiency represents the most common cause of microcytic anemia (low MCV) and affects substantial proportions of athletic populations. The condition progresses through stages, with MCV changes typically emerging during later phases when hemoglobin synthesis becomes significantly impaired.
Stage I iron deficiency (depleted stores with normal hemoglobin) typically produces no MCV changes. During Stage II (latent deficiency), MCV may begin decreasing as iron availability limits hemoglobin production. Stage III manifests as overt iron deficiency anemia with frank microcytosis, particularly common in female athletes with menstrual blood loss[11].
However, MCV can remain within normal ranges even when iron deficiency significantly impacts athletic performance. Mean corpuscular hemoglobin (MCH) may prove more sensitive for early iron restriction detection, as hemoglobin content decreases before substantial volume reduction occurs[12].
A high MCV value, on the other hand in the context of anemia may suggest megaloblastic anemia, most commonly related to vitamin B12 or folate deficiency, discussed in my blog post about high MCV.
In my clinical practice, changes in MCV often become apparent when patients present with fatigue and decreased performance. In such cases, iron studies are often among the first laboratory tests we order. Many of my female athletic patients, in particular, have iron deficiency, which affects their performance even before anemia develops or changes in MCV occur.
Foot-Strike Hemolysis and Red Blood Cell Turnover
Repetitive mechanical trauma during running produces foot-strike hemolysis, described historically in soldiers who developed hemoglobinuria after prolonged marching[13]. This mechanical destruction of red blood cells significantly exceeds that observed in non-impact sports. Studies comparing runners and cyclists demonstrated running produced substantially greater hemolysis, confirming foot impact as the primary mechanism[14].
After 60km ultramarathon running, athletes demonstrated approximately 50% reductions in haptoglobin (a hemolysis marker) alongside significant MCV decreases[15]. The physiological mechanisms underlying this MCV decrease remain incompletely understood and may reflect complex shifts in red blood cell population dynamics, fluid balance, and acute hematological stress responses.
Contrary to popular assumption, foot-strike hemolysis rarely produces clinically significant anemia in healthy athletes. The body’s compensatory erythropoietic response typically maintains adequate red blood cell mass despite increased turnover[16]. However, cumulative effects during intense training periods may contribute to borderline iron status when combined with inadequate dietary intake or absorption.
Footstrike hemolysis rarely causes anemia or is clinically significant at all. It is usually discovered incidentally. Sometimes patients themselves suspect it and it sometimes causes unnecessary concern for patients. In practical clinical situations, it can be detected if a patient has hemoglobinuria after prolonged physical exertion or if the patient’s hemolysis tests are checked for other reasons.
Conclusion
Mean corpuscular volume provides useful but often misunderstood information when interpreting blood tests in athletes. Although short-term fluctuations in MCV may occur during acute physical stress, such as intense exercise or prolonged competition, these changes are usually transient and tend to normalize after recovery. Current evidence suggests that long-term training itself does not consistently produce large or systematic changes in MCV, and research findings in this area remain heterogeneous.
For this reason, persistent deviations in MCV should not automatically be attributed to training alone. Instead, abnormal values should be interpreted using the same clinical framework as in the general population. In athletes, a low MCV most commonly reflects iron deficiency, which is particularly frequent among endurance athletes and female athletes. Conversely, an elevated MCV in the presence of anemia may suggest macrocytic processes such as vitamin B12 or folate deficiency.
Other exercise-related phenomena may also influence hematological findings. For example, repetitive impact during running can lead to foot-strike hemolysis and increased red blood cell turnover. However, this process rarely causes clinically significant anemia and is often detected only incidentally through laboratory findings such as hemoglobinuria or reduced haptoglobin levels.
In my clinical practice, the interpretation of MCV in athletes is largely similar to that in the general patient population. However, if MCV changes in athletes—particularly in female athletes—it is especially important to evaluate iron status. MCV is typically assessed as part of the basic blood count and is rarely measured separately. On its own it does not establish a diagnosis and must always be interpreted together with other laboratory findings and the clinical context.
References
- https://www.ncbi.nlm.nih.gov/books/NBK545275/
- https://pubmed.ncbi.nlm.nih.gov/9610226/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC7927508/
- https://link.springer.com/article/10.1007/BF00634973
- https://pmc.ncbi.nlm.nih.gov/articles/PMC4147199/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10981411/
- https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0063092
- https://onlinelibrary.wiley.com/doi/10.1111/ijlh.12115
- https://dialnet.unirioja.es/descarga/articulo/6761709.pdf
- https://files.eric.ed.gov/fulltext/EJ1182734.pdf
- https://pmc.ncbi.nlm.nih.gov/articles/PMC2953317/
- https://www.mp.pl/paim/issue/article/15714/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC11698231/
- https://atm.amegroups.org/article/view/25989/html
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3417738/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC5728222/
